Jun 29, 2022 8:45 am EDT CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study
May 26, 2022 7:00 am EDT CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
Apr 25, 2022 7:00 am EDT CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening
Mar 24, 2022 7:00 am EDT CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
Feb 16, 2022 8:00 am EST CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies
Dec 2, 2021 7:00 am EST CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal
Nov 18, 2021 7:00 am EST CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
Nov 15, 2021 7:00 am EST CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs
